Total Payments
$2,130
2024 Payments
$250.00
Companies
14
Transactions
24
Medicare Patients
2,139
Medicare Billing
$311,549
Payment Breakdown by Category
Food & Beverage$2,130 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,130 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $613.95 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $479.25 | 4 | $0 (2020) |
| Relypsa, Inc. | $221.18 | 2 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2024) |
| Biogen, Inc. | $124.99 | 1 | $0 (2019) |
| Shire North American Group Inc | $121.59 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $121.05 | 1 | $0 (2022) |
| Edwards Lifesciences Corporation | $116.80 | 1 | $0 (2017) |
| Allergan Inc. | $67.65 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $45.20 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.00 | 2 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $25.06 | 1 | Boston Scientific Corporation ($25.06) |
| 2022 | $121.05 | 1 | Merck Sharp & Dohme LLC ($121.05) |
| 2021 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2020 | $116.34 | 1 | Novartis Pharmaceuticals Corporation ($116.34) |
| 2019 | $718.35 | 8 | Novartis Pharmaceuticals Corporation ($246.58) |
| 2018 | $41.23 | 2 | Alexion Pharmaceuticals, Inc. ($21.63) |
| 2017 | $732.93 | 8 | AstraZeneca Pharmaceuticals LP ($238.95) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 04/04/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTIC | ||||||
| 11/14/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/08/2022 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $121.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $116.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2019 | Shire North American Group Inc | ADVATE (Biological) | Food and Beverage | In-kind items and services | $121.59 | General |
| Category: HEMATOLOGY | ||||||
| 07/23/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Nephrology | ||||||
| 06/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $67.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/29/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Nephrology | ||||||
| 04/25/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Immunology | ||||||
| 12/20/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Immunology | ||||||
| 12/04/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $116.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $101.93 | General |
| Category: Hyperkalemia | ||||||
| 11/15/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEPHROLOGY | ||||||
| 06/08/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $119.25 | General |
| Category: Hyperkalemia | ||||||
| 05/24/2017 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $116.80 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 424 | 813 | $179,402 | $59,286 |
| 2022 | 4 | 657 | 1,234 | $314,559 | $99,312 |
| 2021 | 6 | 540 | 960 | $241,502 | $78,323 |
| 2020 | 6 | 518 | 870 | $228,487 | $74,627 |
Total Patients
2,139
Total Services
3,877
Medicare Billing
$311,549
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 196 | 536 | $95,944 | $32,867 | 34.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 137 | 140 | $37,660 | $12,778 | 33.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 82 | $21,156 | $7,041 | 33.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $18,144 | $4,840 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,498 | $1,759 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 285 | 717 | $184,986 | $58,272 | 31.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 196 | 202 | $54,338 | $17,285 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 118 | 257 | $46,003 | $14,727 | 32.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 58 | 58 | $29,232 | $9,028 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 232 | 591 | $152,478 | $49,641 | 32.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 180 | 184 | $49,496 | $15,858 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 68 | 121 | $21,659 | $7,129 | 32.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 23 | 23 | $11,592 | $3,688 | 31.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 25 | 25 | $4,725 | $1,506 | 31.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 16 | $1,552 | $500.32 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 202 | 493 | $127,194 | $41,869 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 158 | 162 | $43,578 | $14,110 | 32.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 50 | $25,200 | $8,243 | 32.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 57 | 104 | $18,616 | $6,002 | 32.2% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 20 | 30 | $8,040 | $2,601 | 32.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 31 | 31 | $5,859 | $1,803 | 30.8% |
About Dr. Rudolph Alvarado, M.D
Dr. Rudolph Alvarado, M.D is a Internal Medicine healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750353314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rudolph Alvarado, M.D has received a total of $2,130 in payments from pharmaceutical and medical device companies, with $250.00 received in 2024. These payments were reported across 24 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,130).
As a Medicare-enrolled provider, Alvarado has provided services to 2,139 Medicare beneficiaries, totaling 3,877 services with total Medicare billing of $311,549. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fresno, CA
- Active Since 02/07/2006
- Last Updated 06/15/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750353314
Products in Payments
- ENTRESTO (Drug) $479.25
- BRILINTA (Drug) $363.95
- Veltassa (Drug) $221.18
- ANDEXXA (Biological) $125.00
- FARXIGA (Drug) $125.00
- NUZYRA (Drug) $125.00
- TECFIDERA (Drug) $124.99
- ADVATE (Biological) $121.59
- RECARBRIO (Drug) $121.05
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $116.80
- AVYCAZ (Drug) $67.65
- SOLIRIS (Drug) $45.20
- Parsabiv (Biological) $36.53
- WaveWriter Alpha Prime 16 (Device) $25.06
- SAMSCA (Drug) $16.10
- Velphoro (Drug) $15.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fresno
Vijay Balasubramanian, Md, MD
Internal Medicine — Payments: $427,472
Internal Medicine $427,472
Dr. Muhammad Alam, M.d, M.D
Internal Medicine — Payments: $155,229
Internal Medicine $155,229
Muhammad Sheikh, M.d, M.D
Internal Medicine — Payments: $129,097
Internal Medicine $129,097
Dr. Jaya Krishna Chintanaboina, Md, MD
Internal Medicine — Payments: $96,723
Internal Medicine $96,723
Dr. Marina Roytman, M.d, M.D
Internal Medicine — Payments: $95,626
Internal Medicine $95,626
Amardeep Aulakh, D.o, D.O
Internal Medicine — Payments: $58,257
Internal Medicine $58,257